Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine.
from Reuters: Health https://ift.tt/2PelBlT
No comments:
Post a Comment